About Medrhans Pharmaceuticals Private Limited
Data last updated:
Medrhans Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74990TG2018PTC128888. Its GSTIN is 36AAMCM2813N1Z3 (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.22 Cr. It is led by directors including Vanga Kondalreddy and Chiranjeevi Gadupudi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plotno:91 Road No:4 Second Floor Himapuri Colony Mansoorabad Lb Nagar, Hyderabad, Telangana, India – 500068.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.54 Cr, a growth of 107% compared to the previous year. For the same year it recorded a net profit of ₹10.38 Lakh (net margin 1.2%) and EBITDA of ₹42.05 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 86% over three years and 74% over five years.
As per MCA filings, the company has open charges of ₹2.2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medrhans.com.
Company details
Contact details
Medrhans Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is medrhans.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlotno:91 Road No:4 Second Floor Himapuri Colony Mansoorabad Lb Nagar, Hyderabad, Telangana, India – 500068
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medrhans Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medrhans Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medrhans Pharmaceuticals Private Limited, buy the company report.
Financials of Medrhans Pharmaceuticals Private Limited
FY 2025 filings availableMedrhans Pharmaceuticals Private Limited reported revenue of ₹8.54 Cr (up 107% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 74% over five years, including 107% growth in the latest year. EBITDA rose 120% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹42.05 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medrhans Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medrhans Pharmaceuticals Private Limited
Medrhans Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vanga Kondalreddy | Director | 10 Dec 2018 | 7 Years 11 Months | Current |
| Chiranjeevi Gadupudi | Director | 10 Dec 2018 | 7 Years 11 Months | Current |
| Venkateswarlu Nalajala | Director | 10 Dec 2018 | 7 Years 11 Months | Current |
| Gopi Krishna Bobbala | Director | 08 Jul 2019 | 7 Years 4 Months | Current |
Peer comparison
Medrhans Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sameeksha Pharmaceuticals Private Limited | ₹8.61 Cr (FY 2024) | -91.0% | Pune, Maharashtra, India | |||
| Zahidi Pharmaceuticals Private Limited | ₹8.6 Cr (FY 2025) | 2.0% | Umbergaon, Gujarat, India | |||
| Rexcin Pharmaceuticals Private Limited | ₹8.57 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Medrhans Pharmaceuticals Private Limitedthis company | ₹8.54 Cr (FY 2025) | ₹10.38 Lakh | 1.2% | 107.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Medrhans Pharmaceuticals Private Limited, buy the company report.
Auditor
Medrhans Pharmaceuticals Private Limited is audited by Y MADHAVI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Y MADHAVI & ASSOCIATES | FY 2023 | 224740 |
Shareholding
The shareholding of Medrhans Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medrhans Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Dec 2025 | 101200854 | State Bank of India | ₹2.2 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medrhans Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medrhans Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medrhans Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAMCM2813N1Z3 | Telangana | Active | 21 Jan 2019 |
| 19AAMCM2813N1ZZ | West Bengal | Active | 05 Apr 2024 |
To see the full GST registrations and return filing status of Medrhans Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medrhans Pharmaceuticals Private Limited has 5 board changes on record since 2018: 4 appointments and 1 cessation. The latest: Gopi Krishna Bobbala ceased to be Additional Director on 28 Dec 2020.
Frequently asked questions
Medrhans Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 December 2018 (8+ years old) and is registered under CIN U74990TG2018PTC128888.
Medrhans Pharmaceuticals has 4 current directors:
- Vanga Kondalreddy - Director
- Chiranjeevi Gadupudi - Director
- Venkateswarlu Nalajala - Director
- Gopi Krishna Bobbala - Director
The latest financial statements of Medrhans Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Medrhans Pharmaceuticals is 36AAMCM2813N1Z3, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 19AAMCM2813N1ZZ (West Bengal).
The CIN (Corporate Identification Number) of Medrhans Pharmaceuticals is U74990TG2018PTC128888. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medrhans Pharmaceuticals was incorporated on 10 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Medrhans Pharmaceuticals by revenue are Sameeksha Pharmaceuticals Private Limited, Zahidi Pharmaceuticals Private Limited, Rexcin Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gopi Krishna Bobbala ceased to be Additional Director on 28 Dec 2020. Gopi Krishna Bobbala was appointed as Director on 08 Jul 2019. Chiranjeevi Gadupudi was appointed as Director on 10 Dec 2018. Medrhans Pharmaceuticals has 5 board changes on record in total.
Medrhans Pharmaceuticals can be reached through the website medrhans.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Medrhans Pharmaceuticals is at Plotno:91 Road No:4 Second Floor Himapuri Colony Mansoorabad Lb Nagar, Hyderabad, Telangana, India – 500068.
Medrhans Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
